Dyssynergia cerebellaris myoclonica
(Redirected from Primary dentatum atrophy)
Dyssynergia cerebellaris myoclonica is a rare neurological disorder characterized by a combination of myoclonus, ataxia, and other cerebellar symptoms. This condition is also known as Ramsay Hunt syndrome type 1 and is distinct from the more commonly known Ramsay Hunt syndrome type 2, which involves facial paralysis and ear rash due to varicella zoster virus infection.
Symptoms[edit | edit source]
The primary symptoms of Dyssynergia cerebellaris myoclonica include:
- Myoclonus: Sudden, involuntary muscle jerks.
- Ataxia: Lack of muscle coordination affecting voluntary movements.
- Dysarthria: Difficulty in articulating words due to muscle control issues.
- Nystagmus: Rapid, involuntary eye movements.
Causes[edit | edit source]
The exact cause of Dyssynergia cerebellaris myoclonica is not well understood. It is believed to be a genetic disorder, although specific genetic mutations have not been conclusively identified. The condition may be inherited in an autosomal dominant or autosomal recessive manner.
Diagnosis[edit | edit source]
Diagnosis of Dyssynergia cerebellaris myoclonica typically involves:
- Neurological examination: Assessing motor skills, coordination, and reflexes.
- Electromyography (EMG): Measuring electrical activity in muscles.
- Magnetic resonance imaging (MRI): Imaging to detect cerebellar atrophy or other abnormalities.
- Genetic testing: Identifying potential genetic mutations.
Treatment[edit | edit source]
There is no cure for Dyssynergia cerebellaris myoclonica, and treatment focuses on managing symptoms. Options may include:
- Anticonvulsants: Medications such as clonazepam or valproate to control myoclonus.
- Physical therapy: Exercises to improve coordination and balance.
- Speech therapy: Assistance with speech difficulties.
Prognosis[edit | edit source]
The prognosis for individuals with Dyssynergia cerebellaris myoclonica varies. Some may experience a slow progression of symptoms, while others may have a more rapid decline in motor function. Early intervention and supportive therapies can help improve quality of life.
See also[edit | edit source]
References[edit | edit source]
External links[edit | edit source]
-
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD